Shri Ahimsa Naturals logo

Shri Ahimsa Naturals MD, chairman, board of directors and AGM

NSE: SHRIAHIMSAFood Products

Last close ₹398.20up ₹1.75 (0.44%)

Share price at the NSE close on 23 Oct 2026. Previous close ₹396.45.

52-week range of traded prices to 23 Oct 2026
₹210.00Low, 4 Mar 2026₹502.90High, 28 Aug 2026
Market cap
₹948 Cr
P/E
32.6
P/B
4.9
Dividend yield
Nonein the last 12 months
ROE
16.7%
Debt to equity
0.10
Volume, NSE
15,00064.0% delivered

Shri Ahimsa Naturals board of directors

At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

    An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

    Statutory auditor

    Named in the results for the quarter to Mar 2026.

    • Ummed Jain & CoPeer-review certificate valid to Jul 2028

    A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

    Shri Ahimsa Naturals AGM and shareholder votes

    Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Shri Ahimsa Naturals share news and announcements

    Annual general meeting, 14 Sep 2026

    1,458 shareholders on the register on 7 Sep 2026; present: 6 promoters and 15 others; votes counted by Sandeep Kumar Jain / M/S ARMS & Associates LLP.The company's voting result (opens in a new tab)

    1. To consider, review and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2026, prepared on Standalone and Consolidated basis and the reports of the Board of Directors and Auditors thereon.MoreLess
      Ordinary
      100.00% for0.00% against

      Against: promoters 0.00% · institutions 0.00% · other public 0.00%

      Turnout: all 69.14% · promoters 96.55% · institutions 45.73% · other public 3.29%

    2. To consider and re-appoint Mr. Nemi Chand Jain (DIN: 00434383), who retires by rotation and being eligible seeks re-appointment.
      OrdinaryPromoters have an interest in it
      100.00% for0.00% against

      Against: promoters 0.00% · institutions 0.00% · other public 0.00%

      Turnout: all 69.14% · promoters 96.55% · institutions 45.73% · other public 3.29%

    3. To consider and ratify the remuneration of the Cost Auditors for the financial year ending March 31, 2027.
      Ordinary
      100.00% for0.00% against

      Against: promoters 0.00% · institutions 0.00% · other public 0.00%

      Turnout: all 69.14% · promoters 96.55% · institutions 45.73% · other public 3.29%

    For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

    Investor complaints and compliance

    Quarter by quarter.

    Investor complaints received and resolved, the company's own count

    • Received
    • Resolved

    Open at the quarter's end

    None open at any quarter's end.
    The filing has a part on fines and penalties
    No
    The filing has a part on tax disputes
    No

    The company's own answers in its filing.

    How money raised was used

    Reported for the quarter to Mar 2025. The company's results filing for the quarter to Mar 2026 says no statement of how money raised was used applies to it. A statement's amounts are left out where the raise it states is more than ten times everything the company owns, a figure typed at the wrong scale.

    RaisedAmount raisedForSet asideSpentSpent elsewhere
    Public IssuesMar 2025, checked by CARE Ratings Limited–––No
    ₹ crore. Checked by is the agency appointed to monitor how the money is used. The reason and the comments are the company's, its audit committee's and its auditors' own words.